Coherentmarketinsightsus

Peptide drugs are potential therapeutic agent used against several disease attributing to its features high activity, target specificity, low toxicity, and minimal non-specific or drug–drug interactions. The lower physicochemical properties such as for example poor membrane permeability and low target specific action when administered orally demands for improved peptide drug. Glycosylation of peptides is a promising strategy to modulate the physicochemical properties of peptide drugs and for penetration of peptides across biological membranes. Glycosylation of a peptide may be of two type N-linked glycosylation or O-linked glycosylation. Glycosylation of peptide drug enhances bioactivity, selectivity and prolong half-life of therapeutic drug. Advantages provided by glycosylated peptide over conventional peptide drug are the key factor driving growth of the glycosylated peptide market. New product launches by the key manufacturers are fueling growth of the Glycosylated Pept...